Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 120 participants.

Also called NCT01230918

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01230918
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01230918. Allocation not applicable; no masking; primary purpose diagnostic. Start 2011-05 (registry gives no type); primary completion 2017-04-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis
Acronym
SCAR
Condition
Hypertrophic Cardiomyopathy
Condition
Acute Coronary Syndrome
Intervention (Radiation)
99mTc-NC100692
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct01230918
Content hash
317d6b6a67cb2d66d93f341d8eaf8e32c43efd5e8402d0d433cf79f80da87a85